Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE1000032C9

Price
21.71 CNY
Market cap
2.97 bn CNY
P/E (2025)
31.15
P/S (2025)
2.60
Dividend yield
1.84 %
Net margin
8.44 %
Return on equity (ROE)
5.71 %
Return on assets (ROA)
4.14 %

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A financials

Fiscal year20242025
Revenue973.86 m CNY1.14 bn CNY
Gross profit592.12 m CNY591.79 m CNY
Operating income138.37 m CNY122.28 m CNY
EBIT138.51 m CNY111.14 m CNY
Net income120.27 m CNY96.28 m CNY
Diluted EPS – continuing operations1.15 CNY0.70 CNY

Full history since 2013, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines and traditional Chinese medicine formula granules in China. The company offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. It also offers health food, health products, functional health food, and daily chemical products. The company was formerly known as Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd and changed its name to Shaanxi Panlong Pharmaceutical Group Co., Ltd. in May 2026. Shaanxi Panlong Pharmaceutical Group Co., Ltd. was founded in 1997 and is headquartered in Xi'an, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.